Study finds early referrals to hospice care can improve patients’ quality of life and reduce unnecessary emergency room admissionsRead More
Cleveland Clinic researchers have discovered the first example of a genetic alteration that increases the conversion of precursor steroids to 5α-dihydrotestosterone (DHT), permitting prostate tumors to grow in the absence of gonadal testosterone.
Healthcare providers and patients have disparate views of the course of MDS and the value and limitations of treatment. Improved communication and education may increase understanding of the diseases and improve outcomes.
Recent clinical trials have identified new and better ways to treat breast cancer. From exercise for anastrozole arthralgias to promising PARP inhibitors for triple-negative breast cancer, there are many advances.
Promising Cleveland Clinic studies are open to evaluate new agents and regimens for multiple myeloma and amyloidosis. Multidisciplinary support is offered for patients with complex issues.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
In the Y90 radioembolization procedure, interventional radiologists deliver radioactive (Y90) resin or glass-based particles to liver tumors by catheter and provide a continuing radiation dose.
Learn about featured clinical trials currently enrolling or search our trials database.
Clinical studies show that the application of heat to tumors, particularly superficial ones, in combination with radiation produces a better response than radiation alone. The procedure helps address the limitations of repeat radiation for many patients by effectively increasing radiation dose without substantially increasing side effects.
Submicroscopic nanoparticles may help overcome the obstacles that hamper traditional anti-cancer drugs. Their size and other unique properties enable targeted drug delivery to hard-to-access tumors, as well as aiding tumor boundary visualization.
International effort allows experts to confer on complex cases
Apolipoprotein A1, a major component of HDL, blocks metastatic malignant melanoma and lung cancer through multiple pathways. ApoA1 injections not only inhibit tumor growth and progression in mice, but spur tumor and metastases regression.